Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: EyeDrMike who wrote (6958)	4/14/1998 8:40:00 AM
From: sloan	Read Replies (1) \| Respond to of 23519

The action in the stock yesterday leads me to believe that something is very wrong here. Do they have enough money to market the product? Has hteir plant suffered another setback? Has the FDA said something negative? Has some brokerage firm issued a sell on VVUS? There has to be some reason!!!!

To: EyeDrMike who wrote (6958)	4/14/1998 10:33:00 AM
From: Phil Cressman	Read Replies (1) \| Respond to of 23519

It appears misleading to toss about 40% for adverse reaction when at most it would be 40% of the less than 2% of men in trial who reported any adverse reaction. The figure could be more properly stated as less than 1% of men in trial had reactions worthy of mention.